NanoString Technologies (NSTG) Says Study to Date of Prosigna Breast Cancer Assay Published in Journal of Clinical Oncology

February 5, 2018 4:11 PM

NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found